Harbin Pharmaceutical Group Co Ltd - Class A

SHSE:600664 (China)   Class A
Â¥ 2.78 (-1.07%) Jun 13
15.44
P/B:
1.43
Market Cap:
Â¥ 7.01B ($ 966.43M)
Enterprise V:
Â¥ 6.24B ($ 860.11M)
Volume:
27.65M
Avg Vol (2M):
31.89M
Volume:
27.65M
Avg Vol (2M):
31.89M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Harbin Pharmaceutical Group Co Ltd ( ) from 1993 to Jun 13 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Harbin Pharmaceutical Group stock (SHSE:600664) PE ratio as of Jun 13 2024 is 15.44. More Details

Harbin Pharmaceutical Group Co Ltd (SHSE:600664) PE Ratio (TTM) Chart

To

Harbin Pharmaceutical Group Co Ltd (SHSE:600664) PE Ratio (TTM) Historical Data

Total 1206
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Harbin Pharmaceutical Group PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-13 15.4 2024-04-05 16.8
2024-06-12 15.6 2024-04-03 16.8
2024-06-11 15.4 2024-04-02 16.7
2024-06-07 15.4 2024-04-01 16.7
2024-06-06 15.3 2024-03-29 16.4
2024-06-05 15.7 2024-03-28 16.3
2024-06-04 15.9 2024-03-27 18.2
2024-06-03 15.9 2024-03-26 18.3
2024-05-31 16.2 2024-03-25 18.4
2024-05-30 16.1 2024-03-22 18.8
2024-05-29 16.2 2024-03-21 19.1
2024-05-28 16.3 2024-03-20 19.1
2024-05-27 16.6 2024-03-19 19.0
2024-05-24 16.3 2024-03-18 19.1
2024-05-23 16.5 2024-03-15 18.6
2024-05-22 16.9 2024-03-14 18.4
2024-05-21 17.1 2024-03-13 18.4
2024-05-20 17.2 2024-03-12 18.4
2024-05-17 17.2 2024-03-11 18.1
2024-05-16 17.3 2024-03-08 17.7
2024-05-15 17.4 2024-03-07 17.8
2024-05-14 17.6 2024-03-06 17.9
2024-05-13 17.4 2024-03-05 18.0
2024-05-10 17.6 2024-03-04 18.4
2024-05-09 17.6 2024-03-01 18.1
2024-05-08 17.5 2024-02-29 18.1
2024-05-07 17.5 2024-02-28 17.8
2024-05-06 17.6 2024-02-27 18.4
2024-04-30 17.2 2024-02-26 18.3
2024-04-29 16.7 2024-02-23 18.3
2024-04-26 16.7 2024-02-22 18.1
2024-04-25 15.7 2024-02-21 17.9
2024-04-24 15.7 2024-02-20 17.8
2024-04-23 15.6 2024-02-19 17.7
2024-04-22 15.4 2024-02-16 17.5
2024-04-19 15.5 2024-02-09 17.5
2024-04-18 15.6 2024-02-08 17.5
2024-04-17 15.8 2024-02-07 16.4
2024-04-16 15.2 2024-02-06 16.1
2024-04-15 15.8 2024-02-05 15.6
2024-04-12 15.7 2024-02-02 16.6
2024-04-11 16.2 2024-02-01 17.4
2024-04-10 16.6 2024-01-31 17.8
2024-04-09 16.8 2024-01-30 18.6
2024-04-08 16.6 2024-01-29 19.1

Harbin Pharmaceutical Group Co Ltd (SHSE:600664) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Harbin Pharmaceutical Group Co Ltd is engaged in manufacturing, trading and research and development of pharmaceuticals. The company is organized into seven business segments - Antibiotics, Small-Molecular drug preparations, OTC and healthcare products, Modern Chinese medicines, Biopharmaceuticals, Animal vaccines, and medicine circulations. The company sells its products across China and fifty other countries. Some of its brands are - Hayao, Sanjing, Gaizhonggai, Hutong, and Shiyitang.